-+ 0.00%
-+ 0.00%
-+ 0.00%

Clearmind Medicine Submits Patent Application With Intellectual Property Department In Hong Kong

Benzinga·03/13/2026 11:47:07
Listen to the news

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation,  neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the filing of a patent application with the Intellectual Property Department (IPD) in Hong Kong, for am innovative combination therapy designed to treat major depressive disorder (MDD).